dr. sandrine ongeri and dr. nicolo tonali - zoominar on "proteinopathy" (march 21 2022)
Published 2 years ago • 115 plays • Length 1:20:12Download video MP4
Download video MP3
Similar videos
-
1:15:21
dr. ruiqing ni and dr. francesco simone ruggeri - zoominar on "proteinopathy" (oct. 31 2022)
-
29:20
dr. birgit strodel - zoominar on "proteinopathy" (oct. 18 2021)
-
24:41
transcontinental surgery, the surgeon in europe and the patient in china.
-
1:32:19
panel on optimizing conditions for tht-based fluorescence experiments - june 27 2022
-
2:07
addition of lenalidomide to patients with myeloma progressing on ruxolitinib and methylprednisolone
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
5:01
tardive dyskinesia
-
54:17
remyelination & multiple sclerosis with novoron bioscience
-
25:14
regulatory applications of a nonclinical database for oligonucleotide therapeutics at u.s. fda
-
5:36
oligonucleotide and mrna therapeutics with anna collén, astrazeneca
-
0:41
amyloid accumulation in genetic forms of alzheimer’s disease | the lancet neurology
-
1:13
stem cell pioneers win nobel for medicine
-
9:59
amniotic fluid embolism in obstetrics and its management by dr. gurusanthiya s
-
1:00:31
rare drug development symposium: advances in rare disease therapies
-
1:49
dr. maria grazia lazzaroni interview at eular 2019
-
0:54
neo-checkray: chemotherapy and sbrt with durvalumab and oleclumab in er /her2- breast cancer
-
20:23
prognostication in neurocritical care with dr. susanne muehlschlegel
-
1:15
sander s. rubin, md
-
1:20
neod001: the vital amyloidosis study
-
11:26
umdf power surge 2020: alex dorenbaum, md, reneo pharmaceutical
-
1:01:26
systemic amyloidosis: a primer for the nephrologist - erknet webinar with simone baldovino
-
1:03:58
susan catalano - abeta oligomer receptor antagonists as disease modifying alzheimers therapeutics